文献速递妇科

患者来源外植体模型预测子宫内膜癌药物反应

Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2020-12-10

该先导研究利用27例子宫内膜癌患者术后新鲜肿瘤组织建立患者来源外植体(PDE)模型,在气液界面培养16-24小时,评估组织活力和对卡铂/紫杉醇及帕博利珠单抗的药物反应。结果显示PDE可保持组织结构和活力达48小时,自体和血清有助于维持活力,并能评估药物反应差异及肿瘤微环境空间关系。

要点

  • PDE模型可保持子宫内膜癌组织结构和活力长达48小时
  • 自体和血清添加可促进外植体活力
  • PDE平台可评估化疗和免疫检查点抑制剂的差异反应

核心结论

  • PDE平台是一种快速、低成本的临床前模型,可整合入药物开发流程,并有望用于子宫内膜癌的个性化药物检测。

研究设计与样本

  • 先导研究,获取27例子宫内膜癌患者子宫切除术后新鲜肿瘤组织,切成1-3 mm³外植体,在气液界面培养16-24小时。

主要发现

  • 子宫内膜癌样本适用于PDE培养,组织结构保持,活力可维持长达48小时。
  • 自体和血清添加有助于维持PDE活力。
  • PDE平台可评估传统化疗药和免疫检查点抑制剂的差异药物反应,并在保留的肿瘤微环境中进行评估。

临床怎么用

  • PDE模型可用于临床前药物反应预测,支持个性化药物检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To undertake a pilot study to develop a novel Patient-Derived-Explant (PDE) model system for use in endometrial cancer (EC) that is capable of monitoring differential drug responses in a pre-clinical setting. METHODS: Fresh tumour was obtained post-hysterectomy from 27 patients with EC. Tumours were cut into 1-3 mm3 explants that were cultured at the air-liquid interface for 16-24 h in culture media. Explants were cultured in different media conditions to optimise viability. Explants were also treated with carboplatin/paclitaxel or pembrolizumab for 24 h and processed into histology slides. Multiplexed immunofluorescence for Ki67 (proliferation marker), cPARP (apoptosis marker) and CAM 5.2 (tumour mask) was performed followed by image analysis and quantitation of biomarker expression. RESULTS: EC samples are amenable to PDE culture with preserved histological architecture and PDE viability for up to 48 h, with the addition of autologous serum in culture media facilitating EC-PDE viability. Our PDE platform provides evidence of differential drug-response to conventional chemotherapeutics and immune checkpoint inhibition, and these responses can be assessed in the context of a preserved tumour microenvironment. CONCLUSIONS: Our PDE platform represents a rapid, low-cost pre-clinical model which can be easily integrated into drug development pipelines. PDE culture preserves original tumour architecture and enables evaluation of spatial relationships in the tumour microenvironment. PDE culture has the potential for personalised drug-testing in a pre-clinical setting which is increasingly important in an era of personalised medicine in the treatment of EC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Collins A, Miles GJ, Powley IR, et al. Development of a patient-derived explant model for prediction of drug responses in endometrial cancer. Gynecol Oncol. 2020. PMID: 33309417. doi:10.1016/j.ygyno.2020.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。